Vaginal Axis on Magnetic Resonance Imaging After Laparoscopic Pectopexy Surgery: a Controlled Study
Pelvic Organ Prolapse
About this trial
This is an interventional treatment trial for Pelvic Organ Prolapse focused on measuring Magnetic resonance imaging (MRI), vaginal angle, vaginal axis, pelvic organ prolapse (POP)
Eligibility Criteria
In Intervention Group Inclusion Criteria: Women diagnosed with apical pelvic organ prolapse (POP), who did not require an additional posterior colporrhaphy procedure, and desired to undergo uterus-preserving surgery were scheduled for laparoscopic pectopexy. Exclusion Criteria: Women with uterine size greater than 10 cm or a pelvic mass that may alter or interfere with accurate measurement. Women with any congenital or acquired anatomical or reproductive anomaly. Women diagnosed with enterocele through transperineal ultrasound prior to enrollment. Women who require hysterectomy or concomitant pelvic organ prolapse (POP) or anti- incontinence procedure. Women with abnormal uterine bleeding. Women with abnormal cervical screening test results. In Control Group Inclusion Criteria: Nulliparous women without pelvic organ prolapse (asymptomatic grade 1 or less) who presented to the outpatient clinic with complaints other than POP symptoms (e.g., menstrual irregularity) were randomly selected and assigned as the control group. Exclusion Criteria: Women who have given birth previously. Women with a history of pelvic organ prolapse or any pelvic floor disorders. Women who have undergone pelvic surgery. Women with any congenital or acquired anatomical or reproductive anomaly. Women with abnormal uterine bleeding. Women with abnormal cervical screening test results.
Sites / Locations
- Prof. Dr. Cemil Taşcıoğlu City HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
procedure: laparoscopic pectopexy
Nulliparous women with no uterovaginal prolapsed
MRI evaluation will be conducted on eleven participants who underwent laparoscopic pectopexy surgery after one month.
Ten nulliparous participants with no uterovaginal prolapsed will be evaluate by MRI